Promega Breaks Ground on $190M R&D Building: Slideshow

Things have been booming at Promega—literally.

The Fitchburg, WI-based life science supplies business on Wednesday held a groundbreaking ceremony for a 270,000-square-foot research and development facility that the company expects to open in late 2020.

The event, which about 350 people attended, even included a daytime fireworks display. The fireworks were arranged to demonstrate the outline of the future building, according to a company spokesperson.

Promega founder and CEO Bill Linton triggered the display using a handheld remote, as you can see in the above slideshow. The longtime biotech executive, who also has a pilot’s license, was clad in a top hat, vest, and aviator sunglasses.

Promega, which currently has 1,500 employees and brought in revenues of $410 million in fiscal 2017, says the new R&D building will allow the company to add up to 100 jobs by 2023. The Wisconsin Economic Development Corp. said it will provide Promega with up to $185,000 in state income tax credits, which are contingent on the company hitting certain job-creation targets.

The building will be the 12th at Promega’s suburban headquarters, and represents the largest real estate investment the company has made in the four decades it’s been in business.

According to a press release, the new facility will allow Promega to “respond to increasingly complex customer requirements.” The company says it sells 4,000 different products, which are distributed in the U.S. and 100 other countries.

Promega’s products are used in research laboratories, crime labs, and other settings. For example, researchers can use its luciferase assay system for tasks like measuring protein concentration. Another Promega product is the HiBiT protein tagging system, which The Scientist magazine named to its list of the top 10 innovations of 2017.

Author: Jeff Buchanan

Jeff formerly led Xconomy’s Seattle coverage since. Before that, he spent three years as editor of Xconomy Wisconsin, primarily covering software and biotech companies based in the Badger State. A graduate of Vanderbilt, he worked in health IT prior to being bit by the journalism bug.